4 ML norepinephrine 1 MG/ML Injection [Levophed] — RxCUI 209217
RxNorm drug concept · Semantic branded drug
RxCUI 209217
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI209217
Official name4 ML norepinephrine 1 MG/ML Injection [Levophed]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as4 ML Levophed 1 MG/ML Injection; Levophed 4 MG in 4 ML Injection; Levophed 4 MG per 4 ML Injection
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)11 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Norepinephrine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Norepinephrine is used when someone's blood pressure drops to a dangerously low level — low enough to put the brain, heart, and other organs at risk. It works very quickly to bring...
- Why is my loved one receiving norepinephrine in the ICU?
- The medical team will be watching closely for a few important things. The biggest concern is that if the IV leaks, norepinephrine can damage the tissue around the site — so any pai...
- Can norepinephrine cause any serious problems I should watch for?
🕸️ Concept Web — How 4 ML norepinephrine 1 MG/ML Injection [Levophed] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
4 ML norepinephrine 1 MG/ML Injection [Levophed]
RxCUI 209217 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Norepinephrine
7512IN
-
Norepinephrine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Levophed
227559BN
-
Levophed
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Norepinephrine Injection
1745276SCDF -
Norepinephrine Injectable Product
1159845SCDG -
Norepinephrine Injection [Levophed]
1745278SBDF -
Levophed Injectable Product
1167947SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Norepinephrine Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
4 ML norepinephrine 1 MG/ML Injection
242969SCD -
Norepinephrine 1 MG/ML
328853SCDC -
Norepinephrine 1 MG/ML [Levophed]
569844SBDC
-
4 ML norepinephrine 1 MG/ML Injection
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
4 ML norepinephrine 1 MG/ML Injection
SCD · 242969 -
Norepinephrine 1 MG/ML
SCDC · 328853 -
Norepinephrine Injection
SCDF · 1745276 -
Norepinephrine Injectable Product
SCDG · 1159845
Brand-Name Concepts
-
Norepinephrine 1 MG/ML [Levophed]
SBDC · 569844 -
Norepinephrine Injection [Levophed]
SBDF · 1745278 -
Levophed Injectable Product
SBDG · 1167947 -
Levophed
BN · 227559
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 209217 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00409-0161-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-0161-10) / 4 mL in 1... | LEVOPHED | Hospira, Inc. | 2024-03-11 |
| 00409-3375-04 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3375-04) / 4 mL in 1... | LEVOPHED | Hospira, Inc. | 2009-04-27 |
Observed labelers:
Hospira, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.